Fundz

Twist Bioscience Corp reported raising $37 Million in an initial SEC Form D filing, from an offering of $37 Million

PUBLIC · TWSTJun 11, 2015

Amount Raised

$37 Million

$37 Million sold, per SEC Form D (first sale Jun 11, 2015)

Round Type

Venture

San FranciscoManufacturingBiotechnology

Quick answer

Twist Bioscience raised $37 Million in a funding round, dated June 11, 2015. Twist Bioscience is based in San Francisco, California, United States.

How much did Twist Bioscience raise?
Twist Bioscience raised $37 Million in a funding round on June 11, 2015.
What does Twist Bioscience do?
Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology.
Where is Twist Bioscience based and how big is it?
Twist Bioscience is based in San Francisco, California, United States. Fundz records about 930 employees.
Who are the decision-makers at Twist Bioscience?
Fundz holds 1 contact at Twist Bioscience. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Manufacturing and Biotechnology around the same time

Companies in the same sectors as Twist Bioscience that raised within 45 days of this round, from Fundz verified event records.

  • Ginkgo Bioworks raised $50M on July 23, 2015.
  • Procyrion raised $5.2M on July 13, 2015.
  • Hamilton Thorne raised $1.2M (Seed) on June 24, 2015.
  • Meta Materials raised $9.8M on June 18, 2015.
  • Intensity Therapeutics raised $500K (Seed) on June 12, 2015.
  • TransMedics Group raised $64M on June 4, 2015.

Who to call at Twist Bioscience, and when

A new round usually means Twist Bioscience is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Twist Bioscience raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Twist Bioscience, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Twist Bioscience. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Twist Bioscience

Location

455 MISSION BAY BOULEVARD SOUTH

San Francisco, California, United States

About

Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of the platform is a proprietary technology that pioneers a new method of manufacturing synthetic DNA by “writing” DNA on a silicon chip. Twist is leveraging its unique technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation, and antibody libraries for drug discovery and development. Twist is also pursuing longer-term opportunities in digital data storage in DNA and biologics drug discovery. Twist makes products for use across many industries including healthcare, industrial chemicals, agriculture and academic research. Follow us on Twitter | Facebook | LinkedIn | YouTube

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Twist Bioscience raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts26 people are listed at Twist Bioscience. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Twist Bioscience's next move

See what Strategic adds

Twist Bioscience raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.